Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn

Links shared publicly online about this topic.

  • 0
    total visits

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn

fda.gov —

Conflicting results from different studies makes it premature to reach any conclusion about a possible link between SSRI use in pregnancy and PPHN.

View full resource at fda.gov

Tags: Heart Disease, High Blood Pressure, Antidepressant, Drug, Children's Health, Pregnancy, Safety

  • Share

Most Recently Shared on December 19, 2011 at 8:50 pm By:

mhaofnyc MHA of NYC

The FDA issued a warning on the use of SSRI antidepressants by women during pregnancy: http://t.co/G2WTS7hC #mentalhealth #pregnancy

4 months ago...

Reply

Retweet

Favorite

Also Shared By:

Dawn McKinney, MS/RN Dawn McKinney, MS/RN

Advertisement